Register Login

NUVALENT, INC. (NUVL)

Balcom Alexandra 🟡 adjusted position in 25.1K shares (1 derivative) of Nuvalent, Inc. (NUVL) at $100.16 ($2.5M) Transaction Date: Mar 24, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot March 26, 2026, 8:31 p.m.

    🔍 Balcom Alexandra (Executive)

    Company: Nuvalent, Inc. (NUVL)

    Report Date: 2026-03-24

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 11,430
    • Total shares sold: 36,560

    Detailed Transactions and Holdings:

    • Acquired 11,430 shares of Class A Common Stock at $1.08 per share (Direct)
      Date: 2026-03-24 | Code: M | equity_swap_involved: false | shares_owned_after: 110,663.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,599 shares of Class A Common Stock at $95.03 per share (Direct)
      Date: 2026-03-24 | Code: S | equity_swap_involved: false | shares_owned_after: 108,064.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 7,671 shares of Class A Common Stock at $95.88 per share (Direct)
      Date: 2026-03-24 | Code: S | equity_swap_involved: false | shares_owned_after: 100,393.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 1,160 shares of Class A Common Stock at $96.5 per share (Direct)
      Date: 2026-03-24 | Code: S | equity_swap_involved: false | shares_owned_after: 99,233.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 13,700 shares of Class A Common Stock at $100.16 per share (Direct)
      Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 85,533.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 11,430 shares of Stock Option (Right to Buy) at $1.08 per share (Derivative)
      Date: 2026-03-24 | Code: M | Expires: 2031-02-16 | equity_swap_involved: false | shares_owned_after: 150,226.00 | transaction_form_type: 4 | Footnotes: F1, F6

    Footnotes:

    • F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025.
    • F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.34 to $95.33, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4.
    • F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.35 to $96.34, inclusive.
    • F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.35 to $96.72, inclusive.
    • F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.61, inclusive.
    • F6: The shares underlying this option are fully vested.

Search

News categories